CHEK2 and prostate cancer: Additionally, our patient with DFSP and the CHEK2 germline variant p.(Glu64Lys) developed prostate cancer, another CHEK2-associated cancer, suggesting that this genetic alteration could be damaging to CHK2 activity and predispose to cancer formation.14